CA
GILD icon

Claro Advisors’s Gilead Sciences GILD Stock Holding History

Claro Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-600
Closed -$1K – 466
2018
Q4 		$1K Buy
+600
New +$41.9K ﹤0.01% 1009

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Claro Advisors's GILD Position: Q2 2026 in Review

Claro Advisors reduced its Gilead Sciences (GILD) stake by 0.74% in Q2 2026, selling an estimated $4.08K and leaving 4,163 shares worth $526K. The position accounts for 0.06% of the portfolio, ranked #261.

Claro Advisors first reported a position in GILD in Q4 2018 and has held it in 29 quarters since. The position peaked at $1.22M in Q1 2025. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Claro Advisors held 4,163 shares of Gilead Sciences worth $526K as of Q2 2026.
  • Claro Advisors sold 31 Gilead Sciences shares in Q2 2026, an estimated $4.08K.
  • Gilead Sciences made up 0.06% of Claro Advisors's portfolio in Q2 2026, its #261 holding.
  • Claro Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 29 quarters since.
  • Claro Advisors's Gilead Sciences position peaked at $1.22M in Q1 2025.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Claro Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.